TekPackaging wins contract for manufacturing ear thermometer probe covers

NewsGuard 100/100 Score

ESCO Technologies Inc. (NYSE: ESE) today announced that TekPackaging LLC (Tek) has been awarded a production contract to be the exclusive manufacturer of Thermoscan(R) ear thermometer probe covers for distribution worldwide. Thermoscan is the market leader and healthcare industry standard for electronic thermometers.

The total value of the five-year contract is anticipated to be approximately $40 to $50 million with the initial order received for $11.7 million. Deliveries are scheduled to begin in the second half of fiscal 2010.

Randy Loga, President of Tek, commented, "This win is the largest supply contract in our history. We were able to win this project as a result of our commitment to manufacturing excellence and our ability to deliver high-quality, high-volume solutions on time and on budget. We are extremely pleased to be the sole source provider of this product solution."

Vic Richey, ESCO's Chairman and CEO, commented, "This win further validates our reputation as a best cost producer of highly engineered products, and I'm excited about this opportunity to expand our reach in this industry. We recognize the value of the diversity of our end markets as we continue to recognize major contributions within all of our operating units."

Tek, retained by ESCO subsequent to the fiscal 2008 divestiture of Filtertek Inc., is a leading provider of innovative thermoformed solutions for complex packaging applications.

Source: http://www.escotechnologies.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Navigating the complexities of controlled release drug formulations